You are here

In-Space Manufacturing of Microfluidic Chips for Biological Research

Award Information
Agency: National Aeronautics and Space Administration
Branch: N/A
Contract: 80NSSC19C0313
Agency Tracking Number: 192768
Amount: $124,893.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: H8
Solicitation Number: SBIR_19_P1
Solicitation Year: 2019
Award Year: 2019
Award Start Date (Proposal Award Date): 2019-08-19
Award End Date (Contract End Date): 2020-02-18
Small Business Information
7200 Highway 150, Greenville, IN, 47124-9515
DUNS: 621970383
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Eugene Boland
 (812) 923-9591
Business Contact
 Juanita Melton
Phone: (812) 728-8135
Research Institution
According to a recent Grand View Research report, the global 3D bioprinting market size was valued at USD 965.0 million in 2018 and is anticipated to grow at over 19.5% for the next 10 years. This includes all aspects of medical materials including metals, plastics, ceramics, biomaterials, cells, tissues and organ substitutes.nbsp; Advances in bioprinting are gaining importance and the tissues generated will soon become available for transplantation. In parallel, however, the use of human tissue analogs is becoming increasing valuable in drug discovery.nbsp; The tissue chip and micro-organ fields are growing at compound annual growth rate exceeding 34%.nbsp; These technologies and products are collectively known as organs-on-chips (OOCs).nbsp;nbsp;OOCs are microfluidic 3D cell culture devices that closely mimic the key physiological functions of body organs. The chips are not designed to mimic an entire organ but simulate the physiology of a single functional unit of an organ system. They have resulted from scientific advances in cell biology, microfabrication and microfluidics which allow the emulation of the human micro environment in vitro. This unique feature of OOCs is made possible by integrating biology with advanced engineering technologies such as bioprinting. Human OOCs are miniaturized versions of lungs, livers, kidneys, heart, brain, intestines and other vital human organs embedded in a chip.nbsp;The OOC and bioprinting fields are intrinsically linked and many groups, including Techshot researchers, are looking to leverage bioprinting OOCs to circumvent fundamental structural challenges faced in the race to bioprint large-scale organs for research and discovery.nbsp; To this end, Techshot has designed and built the first multi-head, ISS resident bioprinter with culture capability. The methods and system we are proposing here could print micro-organs in this facility to address the emerging OOC market and exploit the unique research potentials in microgravity.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government